Jacky Luiten

Iodine seed ‐ versus wire ‐ guided localization in breast ‐ conserving surgery for non ‐ palpable DCIS | 93 6 References 1. Campbell ID, Royle GT, Coddington R, Theaker J, Rubin CM, Guyer PB et al. Technique and results of localization biopsy in a breast screening programme. Br J Surg 1991;78:1113 ‐ 1115. 2. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL et al. Nation ‐ wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990–1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 1998;75:694 ‐ 698. 3. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2009;115:181 ‐ 183. 4. van Riet YE, Jansen FH, van Beek M, van de Velde CJ, Rutten HJ, Nieuwenhuijzen GA. Localization of non ‐ palpable breast cancer using a radiolabelled titanium seed. Br J Surg 2010;97:1240 ‐ 1245. 5. van der Heiden ‐ van der Loo M, de Munck L, Visser O, Westenend PJ, van Dalen T, Menke MB et al. Variation between hospitals in surgical margins after first breast ‐ conserving surgery in the Netherlands. Breast Cancer Res Treat 2012;131:691 ‐ 698. 6. Postma EL, Verkooijen HM, van Esser S, Hobbelink MG, van der Schelling GP, Koelemij R et al. Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire ‐ guided localisation’ (WGL) in breast conserving surgery for non ‐ palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat 2012;136:469 ‐ 478. 7. Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non ‐ palpable breast cancers: a meta ‐ analysis. J Surg Oncol 2012;105:852 ‐ 858. 8. Gobardhan PD, deWall LL, van der Laan L, ten Tije AJ, van der Meer DC, Tetteroo E et al. The role of radioactive iodine ‐ 125 seed localization in breast ‐ conserving therapy following neoadjuvant chemotherapy. Ann Oncol 2013;24:668 ‐ 673. 9. Gray RJ, Giuliano R, Dauway EL, Cox CE, Reintgen DS. Radioguida nce for nonpalpable primary lesions and sentinel lymph node(s). Am J Su rg 2001;182:404 ‐ 406. 10. NABON. Richtlijn mammacarcinoom; 2008. http://www.oncoline.nl/ [accessed 1 March 2015]. 11. Wapnir IL,Wartenberg DE, Greco RS. Thre e dimensional staging of breast cancer. Breast Cancer Re s Treat 1996;41:15 ‐ 19. 12. Ov erheid.nl. Besluit van 16 juli 2001, houdende vaststelling van het besluit stralingsbescherming, 12. http://wetten.overheid.nl/BWBR0012702/ [accessed 1 March 2015]. 13. Ver kooijen HM, Peeters PH, Buskens E, Koot VC , Borel Rinkes IH, MaliWP et al. Diagnostic accuracy of large ‐ core needle biopsy for nonpalpable breast disease: a meta ‐ analysis. Br J Cancer 2000;82:1017 ‐ 1021. 14. Thind CR, Desmond S, Harris O, Nadeem R, Chagla LS, Audisio RA. Radio ‐ guided localization of clinically occult breast lesions (ROLL): a DGH experience. Clin Radiol 2005;60:681 ‐ 686. 15. Ocal K, Dag A, Turkmenoglu O, Gunay EC, Yucel E, Duce MN. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo) 2011;66:1003-1007. 16. Lovrics PJ, Goldsmith CH, Hodgson N, McCready D, Gohla G, Boylan C et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol 2011;18:3407-3414. 17. Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol 2011;37:388-397. 18. Gobardhan PD, Djamin RS, Romme PJ, deWit PE, de Groot HG, Adriaensen T et al. The use of iodine seed (I-125) as a marker for the localisation of lung nodules in minimal invasive pulmonary surgery. Eur J Surg Oncol 2013;39:945-950.